{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:22Z","timestamp":1786985002008,"version":"build-2736575974"},"reference-count":192,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbcan.2025.189398","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:07:56Z","timestamp":1753369676000},"page":"189398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanism of interleukin-6 cytokine family in bone metastasis of lung cancer and prospects for its application"],"prefix":"10.1016","volume":"1880","author":[{"given":"Jinbai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189398_bb0010","doi-asserted-by":"crossref","first-page":"8818","DOI":"10.21037\/apm-21-1595","article-title":"Mutational characteristics of bone metastasis of lung cancer","volume":"10","author":"Huang","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"20","key":"10.1016\/j.bbcan.2025.189398_bb0015","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157917","article-title":"IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer","volume":"132","author":"He","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189398_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102002","article-title":"Non-coding RNA in exosomes: regulating bone metastasis of lung cancer and its clinical application prospect","volume":"46","author":"Yang","year":"2024","journal-title":"Transl. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.job.2019.02.002","article-title":"Bone metastasis: interaction between cancer cells and bone microenvironment","volume":"61","author":"Hiraga","year":"2019","journal-title":"J Oral Biosci"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.cr.7290266","article-title":"Mechanisms of cancer metastasis to the bone","volume":"15","author":"Yin","year":"2005","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41568-021-00406-5","article-title":"Evolving cancer-niche interactions and therapeutic targets during bone metastasis","volume":"22","author":"Satcher","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189398_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122989","article-title":"Underlying facets of Cancer metastasis","volume":"14","author":"Tyagi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189398_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2407-11-365","article-title":"Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer","volume":"11","author":"Roy","year":"2011","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0050","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.7150\/thno.42218","article-title":"Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060516","article-title":"The roles of fibrinolytic factors in bone destruction caused by inflammation","volume":"13","author":"Kanno","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189398_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/1471-2407-14-225","article-title":"Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12\/SDF-1 expression in the metastatic niches","volume":"14","author":"Roy","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299028","article-title":"IL-17A deficiency inhibits lung cancer-induced osteoclastogenesis by promoting apoptosis of osteoclast precursor cells","volume":"19","author":"Wang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189398_bb0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.actbio.2023.07.059","article-title":"Immunotherapeutic treatment of lung cancer and bone metastasis with a mPLA\/mRNA tumor vaccine","volume":"169","author":"Ma","year":"2023","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","article-title":"Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0080","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 Family Cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189398_bb0085","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189398_bb0090","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1648","article-title":"New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions","volume":"5","author":"Hunter","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","article-title":"Leukemia inhibitory factor (LIF)","volume":"26","author":"Nicola","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0105","article-title":"Historical overview of the interleukin-6 family cytokine","volume":"217","author":"Kang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2025.189398_bb0110","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3389\/fimmu.2020.01424","article-title":"Structural understanding of interleukin 6 family cytokine signaling and targeted therapies: focus on interleukin 11","volume":"11","author":"Metcalfe","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115327","article-title":"A panoramic review of IL-6: structure, pathophysiological roles and inhibitors","volume":"28","author":"Kaur","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0120","doi-asserted-by":"crossref","first-page":"202","DOI":"10.21037\/apm-20-2229","article-title":"Serum IL-6 as a vital predictor of severe lung cancer","volume":"10","author":"An","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010612","article-title":"Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6\/Jak\/Stat3 in PD-L1-high lung cancer","volume":"13","author":"Jeong","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0130","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5055","article-title":"Silencing of ISLR inhibits tumour progression and glycolysis by inactivating the IL-6\/JAK\/STAT3 pathway in non-small cell lung cancer","volume":"48","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0135","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","article-title":"JAK\/STAT3 signaling is required for TGF-\u03b2-induced epithelial-mesenchymal transition in lung cancer cells","volume":"44","author":"Liu","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0140","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809976","article-title":"ADAM17 selectively activates the IL-6 trans-signaling\/ERK MAPK axis in KRAS-addicted lung cancer","volume":"11","author":"Saad","year":"2019","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0145","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1159\/000488166","article-title":"Upregulation of IL-11, an IL-6 family cytokine, promotes tumor progression and correlates with poor prognosis in non-small cell lung Cancer","volume":"45","author":"Zhao","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbcan.2025.189398_bb0150","doi-asserted-by":"crossref","DOI":"10.1177\/15347354231187000","article-title":"Xiaoliu Pingyi Pecipe inhibits lung pre-metastatic niche formation and prevents myeloid-derived suppressor cells recruitment","volume":"22","author":"Li","year":"2023","journal-title":"Integr. Cancer Ther."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189398_bb0155","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10585-014-9680-3","article-title":"Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone","volume":"31","author":"Zheng","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0160","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.3892\/ol.2017.6048","article-title":"IL-6 and TNF-alpha promote metastasis of lung cancer by inducing epithelial-mesenchymal transition","volume":"13","author":"Shang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020326","article-title":"GP130 cytokines in breast Cancer and bone","volume":"12","author":"Omokehinde","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0170","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.7150\/ijbs.94339","article-title":"Cigarette smoke promotes IL-6-dependent lung cancer migration and osteolytic bone metastasis","volume":"20","author":"Guo","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14010089","article-title":"Interleukin-11\/IL-11 receptor promotes glioblastoma cell proliferation, Epithelial-Mesenchymal Transition, and Invasion","volume":"14","author":"Stuart","year":"2024","journal-title":"Brain Sci"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41419-019-1594-1","article-title":"IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis","volume":"10","author":"Liang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189398_bb0185","first-page":"2595","article-title":"Long non-coding RNA NKILA inhibits proliferation and migration of lung cancer via IL-11\/STAT3 signaling","volume":"12","author":"Liu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0190","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s12032-013-0634-4","article-title":"Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130\/STAT3 pathway","volume":"30","author":"Ren","year":"2013","journal-title":"Med. Oncol."},{"issue":"37","key":"10.1016\/j.bbcan.2025.189398_bb0195","doi-asserted-by":"crossref","first-page":"60395","DOI":"10.18632\/oncotarget.10939","article-title":"Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189398_bb0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.trsl.2024.05.010","article-title":"Spleen derived monocytes regulate pulmonary vascular permeability in Hepatopulmonary syndrome through the OSM-FGF\/FGFR1 signaling","volume":"271","author":"Li","year":"2024","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0205","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2018.03.056","article-title":"Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3)","volume":"498","author":"Sterbova","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1947601912458284","article-title":"Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation","volume":"3","author":"Bolin","year":"2012","journal-title":"Genes Cancer"},{"issue":"16","key":"10.1016\/j.bbcan.2025.189398_bb0215","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1158\/0008-5472.CAN-09-4653","article-title":"Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment","volume":"70","author":"Miki","year":"2010","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2220\/biomedres.27.197","article-title":"Inhibition effect of Oncostatin M on metastatic human lung cancer cells 95-D in vitro and on murine melanoma cells B16BL6 in vivo","volume":"27","author":"Ouyang","year":"2006","journal-title":"Biomed. Res."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189398_bb0225","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/neuonc\/noae065","article-title":"Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by activating ITGB2 signaling feedback in microglia","volume":"26","author":"Xie","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020217","article-title":"Leukemia inhibitory factor: An important cytokine in pathologies and Cancer","volume":"12","author":"Jorgensen","year":"2022","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0235","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10585-008-9223-x","article-title":"A role for leukemia inhibitory factor in melanoma-induced bone metastasis","volume":"26","author":"Maruta","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0240","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/tox.23104","article-title":"Hsa_circ_0001073 targets miR-626\/LIFR axis to inhibit lung cancer progression","volume":"36","author":"Liu","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bbcan.2025.189398_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155655","article-title":"Influences of the IL-6 cytokine family on bone structure and function","volume":"146","author":"Sims","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.bbcan.2025.189398_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109807","article-title":"Mechanistic insight into the synergism of IL-27 and IL-28B in regulation of benzo(a)pyrene-induced lung carcinogenesis associated ROS\/NF-kappaB\/NLRP3 crosstalk","volume":"354","author":"Majumder","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0255","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.4049\/jimmunol.1201460","article-title":"A polyglutamic acid motif confers IL-27 hydroxyapatite and bone-binding properties","volume":"190","author":"Tormo","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1756-9966-32-97","article-title":"IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer","volume":"32","author":"Kachroo","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189398_bb0265","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2147\/OTT.S173207","article-title":"IL-27 inhibits non-small-cell lung cancer cell metastasis by miR-935 in vitro","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bbcan.2025.189398_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/802939","article-title":"Decreased IL-27 negatively correlated with Th17 cells in non-small-cell lung Cancer patients","volume":"2015","author":"Duan","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbcan.2025.189398_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118384","article-title":"IL-27 along with IL-28B ameliorates the pulmonary redox impairment, inflammation and immunosuppression in benzo(a)pyrene induced lung cancer bearing mice","volume":"260","author":"Majumder","year":"2020","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0280","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.31792","article-title":"Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0285","article-title":"Different roles of matrix metalloproteinase 2 in osteolysis of skeletal dysplasia and bone metastasis (review)","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2025.189398_bb0290","article-title":"The CLCF1-CNTFR axis drives an immunosuppressive tumor microenvironment and blockade enhances the effects of established cancer therapies","author":"Sweet-Cordero","year":"2024","journal-title":"Res Sq"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0295","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/15548627.2022.2090693","article-title":"Tumor-derived CTF1 (cardiotrophin 1) is a critical mediator of stroma-assisted and autophagy-dependent breast cancer cell migration, invasion and metastasis","volume":"19","author":"Akkoc","year":"2023","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041239","article-title":"IL-33\/IL-31 Axis in osteoporosis","volume":"21","author":"De Martinis","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0305","first-page":"348","article-title":"Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer?","volume":"34","author":"Naumnik","year":"2012","journal-title":"Exp. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189398_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105078","article-title":"The role of inflammation in breast and prostate Cancer metastasis to bone","volume":"22","author":"G\u00f6bel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.bbcan.2025.189398_bb0315","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","article-title":"Tumor immune microenvironment during epithelial-mesenchymal transition","volume":"27","author":"Taki","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0320","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-019-0959-5","article-title":"Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"33","key":"10.1016\/j.bbcan.2025.189398_bb0325","doi-asserted-by":"crossref","first-page":"54265","DOI":"10.18632\/oncotarget.17346","article-title":"ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR\/PI3K\/Akt and IL-6\/STAT3 signaling pathways","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.bbcan.2025.189398_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158334","article-title":"The role of the IL-6 cytokine family in epithelial-mesenchymal plasticity in Cancer progression","volume":"22","author":"Abaurrea","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0335","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","article-title":"STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0340","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12776","article-title":"IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-kappaB","volume":"53","author":"Liu","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbcan.2025.189398_bb0345","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.2147\/CMAR.S179189","article-title":"IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis","volume":"10","author":"Browning","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189398_bb0350","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.2174\/1871520621666201207091248","article-title":"Recombinant human IL-11 promotes lung adenocarcinoma A549 cell growth and EMT through activating STAT3\/HIF-1\u03b1\/EMT signaling pathway","volume":"21","author":"Peng","year":"2021","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0355","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189398_bb0360","first-page":"742","article-title":"The vasculature: a vessel for bone metastasis","volume":"4","author":"Raymaekers","year":"2015","journal-title":"Bonekey Rep"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189398_bb0365","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of STAT3 in breast cancer cells: a review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0370","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/path.5871","article-title":"Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis","volume":"257","author":"Di Maira","year":"2022","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189398_bb0375","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1593\/neo.13706","article-title":"The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis","volume":"15","author":"Chang","year":"2013","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0380","doi-asserted-by":"crossref","first-page":"361","DOI":"10.32604\/or.2023.028104","article-title":"Senescent mesenchymal stem\/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients","volume":"31","author":"Borzone","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbcan.2025.189398_bb0385","article-title":"Tumour-derived extracellular vesicle and particle reprogramming of interstitial macrophages in the lung pre-metastatic niche enhances vascular permeability and metastatic potential","author":"Dror","year":"2024","journal-title":"Res Sq"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0390","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563218759371","article-title":"The bone remodelling cycle","volume":"55","author":"Kenkre","year":"2018","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0395","doi-asserted-by":"crossref","first-page":"21199","DOI":"10.1038\/s41598-023-48615-2","article-title":"The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis","volume":"13","author":"Padovano","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0400","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13046-015-0169-y","article-title":"MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN","volume":"34","author":"Wang","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0405","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/toxres\/tfaa053","article-title":"Selenium donors inhibits osteoclastogenesis through inhibiting IL-6 and plays a pivotal role in bone metastasis from breast cancer","volume":"9","author":"Zhang","year":"2020","journal-title":"Toxicol Res (Camb)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0410","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/jcb.25167","article-title":"Expression of the IL-11 gene in metastatic cells is supported by Runx2-Smad and Runx2-cJun complexes induced by TGFbeta1","volume":"116","author":"Zhang","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0415","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12891-021-04886-2","article-title":"Osteoclasts secrete leukemia inhibitory factor to promote abnormal bone remodeling of subchondral bone in osteoarthritis","volume":"23","author":"Zhao","year":"2022","journal-title":"BMC Musculoskelet. Disord."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0420","doi-asserted-by":"crossref","first-page":"13751","DOI":"10.1038\/s41598-020-70817-1","article-title":"Sclerostin expression in trabecular bone is downregulated by osteoclasts","volume":"10","author":"Koide","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0425","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.orthres.2003.03.004","article-title":"Bone resorption activity of osteolytic metastatic lung and breast cancers","volume":"22","author":"Shih","year":"2004","journal-title":"J. Orthop. Res."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0430","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/odi.13745","article-title":"HIF-1alpha regulates osteoclast activation and mediates osteogenesis during mandibular bone repair via CT-1","volume":"28","author":"Tian","year":"2022","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0435","doi-asserted-by":"crossref","first-page":"13838","DOI":"10.1038\/s41598-020-70788-3","article-title":"Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis","volume":"10","author":"Monteran","year":"2020","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.bbcan.2025.189398_bb0440","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1158\/0008-5472.CAN-16-0608","article-title":"Inflammation triggers Zeb1-dependent escape from tumor latency","volume":"76","author":"De Cock","year":"2016","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189398_bb0445","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1878-0261.12095","article-title":"EMT and inflammation: inseparable actors of cancer progression","volume":"11","author":"Suarez-Carmona","year":"2017","journal-title":"Mol. Oncol."},{"issue":"24","key":"10.1016\/j.bbcan.2025.189398_bb0450","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1007\/s00018-020-03572-1","article-title":"Tumour dormancy in inflammatory microenvironment: a promising therapeutic strategy for cancer-related bone metastasis","volume":"77","author":"Hu","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2025.189398_bb0455","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0460","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/bcr3473","article-title":"A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model","volume":"15","author":"Oh","year":"2013","journal-title":"Breast Cancer Res."},{"issue":"19","key":"10.1016\/j.bbcan.2025.189398_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: drivers of Cancer chronic inflammation through HIF-1 and NF-kappaB activation: a review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"26","key":"10.1016\/j.bbcan.2025.189398_bb0470","doi-asserted-by":"crossref","first-page":"39363","DOI":"10.18632\/oncotarget.8101","article-title":"Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189398_bb0475","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cyto.2018.03.032","article-title":"M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis","volume":"118","author":"Shrivastava","year":"2019","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0480","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0485","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/cns.14041","article-title":"Contemplating IL-6, a double-edged sword cytokine: which side to use for stroke pathology?","volume":"29","author":"Monsour","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"26","key":"10.1016\/j.bbcan.2025.189398_bb0490","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/onc.2010.130","article-title":"Novel alternatively spliced ADAM8 isoforms contribute to the aggressive bone metastatic phenotype of lung cancer","volume":"29","author":"Hern\u00e1ndez","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0495","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ijc.29033","article-title":"IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation","volume":"136","author":"Liu","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0500","doi-asserted-by":"crossref","first-page":"8660","DOI":"10.1038\/s41598-017-09020-8","article-title":"Targeted blockade of TGF-beta and IL-6\/JAK2\/STAT3 pathways inhibits lung cancer growth promoted by bone marrow-derived myofibroblasts","volume":"7","author":"Shi","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0505","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/jcp.29194","article-title":"LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-beta pathway and IL-6\/JAK2\/STAT3 pathway","volume":"235","author":"Shi","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0510","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.7150\/ijbs.31999","article-title":"An autocrine IL-6\/IGF-1R loop mediates EMT and promotes tumor growth in non-small cell lung Cancer","volume":"15","author":"Zheng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0515","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3816\/CLC.2006.n.006","article-title":"Autocrine interleukin-6\/interleukin-6 receptor stimulation in non-small-cell lung cancer","volume":"7","author":"Haura","year":"2006","journal-title":"Clin. Lung Cancer"},{"issue":"20 Pt 2","key":"10.1016\/j.bbcan.2025.189398_bb0520","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0525","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/jbmr.2231","article-title":"Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways","volume":"29","author":"Zheng","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0530","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13287-019-1280-3","article-title":"Epidural adipose tissue-derived mesenchymal stem cell activation induced by lung cancer cells promotes malignancy and EMT of lung cancer","volume":"10","author":"Wang","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.bbcan.2025.189398_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071637","article-title":"Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer","volume":"8","author":"Sung","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189398_bb0540","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2018.00339","article-title":"Bone marrow adipocyte: An intimate partner with tumor cells in bone metastasis","volume":"9","author":"Luo","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0545","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00432-020-03277-9","article-title":"Bone marrow adipocytes enhance osteolytic bone destruction by activating 1q21.3(S100A7\/8\/9-IL6R)-TLR4 pathway in lung cancer","volume":"146","author":"Luo","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"Pt A","key":"10.1016\/j.bbcan.2025.189398_bb0550","article-title":"Sevoflurane activates the IL-6\/HO-1 pathway to promote macrophage M2 polarization and prostate cancer lung metastasis","volume":"113","author":"Yu","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0555","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002856","article-title":"IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells","volume":"9","author":"Magidey-Klein","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"7225","key":"10.1016\/j.bbcan.2025.189398_bb0560","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature07623","article-title":"Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis","volume":"457","author":"Kim","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0565","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.1038\/s41467-024-51831-7","article-title":"Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer","volume":"15","author":"Hung","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189398_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155750","article-title":"Emerging roles for IL-11 in inflammatory diseases","volume":"149","author":"Fung","year":"2022","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0575","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2016.01.004","article-title":"The role of IL-11 in immunity and cancer","volume":"373","author":"Xu","year":"2016","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.bbcan.2025.189398_bb0580","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1002\/jcb.24211","article-title":"Interleukin-11 increases cell motility and up-regulates intercellular adhesion molecule-1 expression in human chondrosarcoma cells","volume":"113","author":"Li","year":"2012","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0585","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0590","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.14336\/AD.2023.0306","article-title":"The emerging role of interleukin-(IL)-11\/IL-11R in bone metabolism and homeostasis: from cytokine to Osteokine","volume":"14","author":"Dong","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbcan.2025.189398_bb0595","doi-asserted-by":"crossref","first-page":"1290130","DOI":"10.3389\/fendo.2023.1290130","article-title":"Roles of IL-11 in the regulation of bone metabolism","volume":"14","author":"Han","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0600","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12076","article-title":"miR-495 and miR-5688 are down-regulated in non-small cell lung cancer under hypoxia to maintain interleukin-11 expression","volume":"40","author":"Zhao","year":"2020","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0605","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in Cancer","volume":"134","author":"Massagu\u00e9","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0610","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/s41467-021-21976-w","article-title":"Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0615","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/jcb.25167","article-title":"Expression of the IL-11 gene in metastatic cells is supported by Runx2-Smad and Runx2-cJun complexes induced by TGF\u03b21","volume":"116","author":"Zhang","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0620","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/17246008211023515","article-title":"Clinical value of serum and exhaled breath condensate inflammatory factor IL-11 levels in non-small cell lung cancer: clinical value of IL-11 in non-small cell lung cancer","volume":"36","author":"Wu","year":"2021","journal-title":"Int. J. Biol. Markers"},{"issue":"14","key":"10.1016\/j.bbcan.2025.189398_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142257","article-title":"Interleukin-11: a potential biomarker and molecular therapeutic target in non-small cell lung Cancer","volume":"11","author":"Leung","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189398_bb0630","doi-asserted-by":"crossref","first-page":"1239732","DOI":"10.3389\/fimmu.2023.1239732","article-title":"The clinical relevance of OSM in inflammatory diseases: a comprehensive review","volume":"14","author":"Wolf","year":"2023","journal-title":"Front. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.bbcan.2025.189398_bb0635","first-page":"1","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0640","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/jcb.29401","article-title":"miR-181b\/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation","volume":"121","author":"Han","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189398_bb0645","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-17-0148","article-title":"JAK1\/STAT3 activation through a Proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung Cancer","volume":"16","author":"Shien","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"22","key":"10.1016\/j.bbcan.2025.189398_bb0650","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1158\/0008-5472.CAN-12-1568","article-title":"Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.bbcan.2025.189398_bb0655","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Hypoxic Exosomal circPLEKHM1-mediated crosstalk between tumor cells and macrophages drives lung Cancer metastasis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0660","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13058-018-0971-5","article-title":"OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung","volume":"20","author":"Tawara","year":"2018","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0665","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/stem.1040","article-title":"Induction of osteogenesis in mesenchymal stem cells by activated monocytes\/macrophages depends on oncostatin M signaling","volume":"30","author":"Guihard","year":"2012","journal-title":"Stem Cells"},{"issue":"24","key":"10.1016\/j.bbcan.2025.189398_bb0670","doi-asserted-by":"crossref","first-page":"18061","DOI":"10.1074\/jbc.M907962199","article-title":"Oncostatin M and transforming growth factor-beta 1 induce post-translational modification and hyaluronan binding to CD44 in lung-derived epithelial tumor cells","volume":"275","author":"Cichy","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0675","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/cyto.2001.1018","article-title":"Oncostatin M induces tissue-type plasminogen activator and plasminogen activator inhibitor-1 in Calu-1 lung carcinoma cells","volume":"18","author":"Spence","year":"2002","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0680","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymthe.2022.12.016","article-title":"Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0685","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/labinvest.3700216","article-title":"Endogenous leukemia inhibitory factor attenuates endotoxin response","volume":"85","author":"Weber","year":"2005","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbcan.2025.189398_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107754","article-title":"The emerging role of leukemia inhibitory factor in cancer and therapy","volume":"221","author":"Zhang","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0695","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3892\/ol.2021.12924","article-title":"Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathway","volume":"22","author":"Wang","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2025.189398_bb0700","doi-asserted-by":"crossref","DOI":"10.1002\/psp4.13204","article-title":"A mechanistic PK\/PD model of AZD0171 (anti-LIF) to support phase II dose selection","author":"Shahraz","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0705","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1359\/jbmr.1998.13.3.400","article-title":"The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway","volume":"13","author":"Akatsu","year":"1998","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0710","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1111\/cas.14131","article-title":"Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)-182\/miR-93-leukemia inhibitory factor receptor pathway","volume":"110","author":"Wang","year":"2019","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189398_bb0715","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncb3408","article-title":"Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow","volume":"18","author":"Johnson","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189398_bb0720","doi-asserted-by":"crossref","first-page":"1259336","DOI":"10.3389\/fmolb.2023.1259336","article-title":"Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer","volume":"10","author":"Kumar","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"8055","key":"10.1016\/j.bbcan.2025.189398_bb0725","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41586-024-08510-w","article-title":"IL-27 elicits a cytotoxic CD8(+) T cell program to enforce tumour control","volume":"639","author":"Br\u00e9art","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0730","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.23060","article-title":"STAT heterodimers in immunity: a mixed message or a unique signal?","volume":"2","author":"Delgoffe","year":"2013","journal-title":"Jak-stat"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0735","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13046-017-0608-z","article-title":"IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient small cell lung Cancer cells","volume":"36","author":"Carbotti","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189398_bb0740","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1359\/jbmr.080706","article-title":"Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling","volume":"23","author":"Walker","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0745","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1096\/fj.201801563R","article-title":"Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization","volume":"33","author":"Carneros","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2025.189398_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116140","article-title":"Cardiotrophin like cytokine factor 1 (CLCF1) alleviates bone loss in osteoporosis mouse models by suppressing osteoclast differentiation through activating interferon signaling and repressing the nuclear factor-\u03baB signaling pathway","volume":"153","author":"Yokota","year":"2021","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bbcan.2025.189398_bb0755","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41591-019-0612-2","article-title":"Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma","volume":"25","author":"Kim","year":"2019","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0760","first-page":"291","article-title":"Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling","volume":"15","author":"Diveu","year":"2004","journal-title":"Eur. Cytokine Netw."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0765","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/gtmb.2017.0256","article-title":"The role of Interleukin-31 polymorphisms in non-small cell lung Cancer genetic susceptibility and clinical outcome","volume":"22","author":"Yang","year":"2018","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.bbcan.2025.189398_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111450","article-title":"The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges","volume":"138","author":"Xie","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"15","key":"10.1016\/j.bbcan.2025.189398_bb0775","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/CM9.0000000000002127","article-title":"Tumor microenvironment in lung cancer-derived brain metastasis","volume":"135","author":"Liu","year":"2022","journal-title":"Chin. Med. J."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189398_bb0780","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/glia.21022","article-title":"Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way","volume":"58","author":"Pukrop","year":"2010","journal-title":"Glia"},{"issue":"14","key":"10.1016\/j.bbcan.2025.189398_bb0785","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.7150\/thno.42234","article-title":"BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0790","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41392-022-00872-9","article-title":"Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0795","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00262-019-02384-y","article-title":"Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer","volume":"68","author":"Li","year":"2019","journal-title":"Cancer Immunol., Immunother. : CII"},{"issue":"26","key":"10.1016\/j.bbcan.2025.189398_bb0800","article-title":"Brain metastasis from EGFR-mutated non-small cell lung Cancer: secretion of IL11 from astrocytes up-regulates PDL1 and promotes immune escape","volume":"11","author":"Tang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0805","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41422-024-00946-z","article-title":"Multiple cancer cell types release LIF and Gal3 to hijack neural signals","volume":"34","author":"Xu","year":"2024","journal-title":"Cell Res."},{"issue":"12","key":"10.1016\/j.bbcan.2025.189398_bb0810","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.21037\/jtd-23-1294","article-title":"A retrospective analysis of prognostic factors and treatment choices in small cell lung cancer with liver metastasis","volume":"15","author":"Zhang","year":"2023","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0815","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","article-title":"Liver metastases","volume":"7","author":"Tsilimigras","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7747","key":"10.1016\/j.bbcan.2025.189398_bb0820","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","article-title":"Hepatocytes direct the formation of a pro-metastatic niche in the liver","volume":"567","author":"Lee","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0825","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.ymthe.2023.07.012","article-title":"Alcohol reshapes a liver premetastatic niche for cancer by extra- and intrahepatic crosstalk-mediated immune evasion","volume":"31","author":"Qiu","year":"2023","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0830","first-page":"323","article-title":"NK cell depletion promotes liver metastasis of lung cancer cells","volume":"56","author":"Yu","year":"2024","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"5\u20136","key":"10.1016\/j.bbcan.2025.189398_bb0835","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clinbiochem.2006.10.027","article-title":"Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis","volume":"40","author":"Matzaraki","year":"2007","journal-title":"Clin. Biochem."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189398_bb0840","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1158\/1078-0432.CCR-22-3379","article-title":"IL6 mediates suppression of T- and NK-cell function in EMT-associated TKI-resistant EGFR-mutant NSCLC","volume":"29","author":"Patel","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0845","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/s41423-021-00731-7","article-title":"Kupffer cell restoration after partial hepatectomy is mainly driven by local cell proliferation in IL-6-dependent autocrine and paracrine manners","volume":"18","author":"Ait Ahmed","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.bbcan.2025.189398_bb0850","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10495-023-01930-5","article-title":"Mechanism of bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells induced by highly metastatic colon cancer cells","volume":"29","author":"Tang","year":"2024","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0855","first-page":"277","article-title":"[adrenal metastasis in primary lung cancer], Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi =","volume":"22","author":"Wang","year":"1999","journal-title":"Chin. J. Ttubercul. Resp. Dis."},{"key":"10.1016\/j.bbcan.2025.189398_bb0860","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1749-6632.2000.tb05428.x","article-title":"Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion","volume":"917","author":"Judd","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2025.189398_bb0865","first-page":"520","article-title":"[advances in lymph node metastasis and lymph node dissection \u07edin early non-small cell lung Cancer], Zhongguo fei ai za zhi =","volume":"22","author":"Lu","year":"2019","journal-title":"Chin. J. Lung Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189398_bb0870","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jare.2016.06.007","article-title":"Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression","volume":"7","author":"Ibrahim","year":"2016","journal-title":"J. Adv. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.bbcan.2025.189398_bb0875","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.4103\/jcrt.jcrt_2225_22","article-title":"The use of interleukin-6 as a biomarker of lung cancer: a systematic review and meta-analysis","volume":"19","author":"Kalali","year":"2023","journal-title":"J. Cancer Res. Ther."},{"issue":"7","key":"10.1016\/j.bbcan.2025.189398_bb0880","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1871530319666190116115226","article-title":"Interleukin-17A: a potential therapeutic target in chronic lung diseases","volume":"19","author":"Shaikh","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.bbcan.2025.189398_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.572616","article-title":"Paeonol suppresses proliferation and motility of non-small-cell lung Cancer cells by disrupting STAT3\/NF-kappaB signaling","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189398_bb0890","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.intimp.2019.04.033","article-title":"Paeonol: pharmacological effects and mechanisms of action","volume":"72","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0895","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/tox.23946","article-title":"6-Shogaol prevents benzo (a) pyrene-exposed lung carcinogenesis via modulating PRDX1-associated oxidative stress, inflammation, and proliferation in mouse models","volume":"39","author":"Pan","year":"2024","journal-title":"Environ. Toxicol."},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0900","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1097-4652(199806)175:3<247::AID-JCP2>3.0.CO;2-O","article-title":"Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors","volume":"175","author":"Morinaga","year":"1998","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.bbcan.2025.189398_bb0905","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/CAD.0000000000000976","article-title":"Icaritin inhibits lung cancer-induced osteoclastogenesis by suppressing the expression of IL-6 and TNF-a and through AMPK\/mTOR signaling pathway","volume":"31","author":"Zhao","year":"2020","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bbcan.2025.189398_bb0910","doi-asserted-by":"crossref","unstructured":"A. Lipton, Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone, Cancer Treat. Rev. 34 Suppl 1 (2008) S25\u201330. doi:https:\/\/doi.org\/10.1016\/j.ctrv.2008.03.008.","DOI":"10.1016\/j.ctrv.2008.03.008"},{"issue":"4","key":"10.1016\/j.bbcan.2025.189398_bb0915","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189398_bb0920","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/jcsm.13638","article-title":"Tocilizumab for advanced non-small-cell lung Cancer with concomitant Cachexia: An observational study","volume":"15","author":"Du","year":"2024","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"18","key":"10.1016\/j.bbcan.2025.189398_bb0925","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184340","article-title":"Inhibition of tyrosine-phosphorylated STAT3 in human breast and lung Cancer cells by Manuka honey is mediated by selective antagonism of the IL-6 receptor","volume":"20","author":"Aryappalli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189398_bb0930","series-title":"Combined JAK Inhibition and PD-1 Immunotherapy for Non-small Cell Lung cancer Patients, Science (New York, N.Y.)","volume":"vol. 384(6702)","author":"Mathew","year":"2024"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189398_bb0935","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1158\/1535-7163.MCT-12-0311","article-title":"Activation of IL-6R\/JAK1\/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation","volume":"11","author":"Kim","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bbcan.2025.189398_bb0940","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00280-021-04369-0","article-title":"A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer","volume":"89","author":"Padda","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189398_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100957","article-title":"A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6\/JAK2\/STAT3 signaling pathway in lung adenocarcinoma","volume":"68","author":"Liang","year":"2023","journal-title":"Drug resistance updates"},{"issue":"3","key":"10.1016\/j.bbcan.2025.189398_bb0950","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cllc.2016.12.003","article-title":"A multicenter double-blind phase II study of metformin with Gefitinib as first-line therapy of locally advanced non-small-cell lung Cancer","volume":"18","author":"Li","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2025.189398_bb0955","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1172\/JCI57158","article-title":"Therapeutic strategies for the clinical blockade of IL-6\/gp130 signaling","volume":"121","author":"Jones","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bbcan.2025.189398_bb0960","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/14728222.2012.660307","article-title":"Hitting a complex target: an update on interleukin-6 trans-signalling","volume":"16","author":"Waetzig","year":"2012","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T21:11:16Z","timestamp":1758143476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25001404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":192,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0304419X25001404"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189398","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of interleukin-6 cytokine family in bone metastasis of lung cancer and prospects for its application","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189398"}}